* MiMedx Group Inc MDXG.OQ MDXG.O is expected to show a
rise
in quarterly revenue when it reports results on February 28 for
the period ending December 31 2023
* The Marietta Georgia-based company is expected to report
a
14.4% increase in revenue to $85.05 million from $74.38 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for MiMedx Group Inc is for
earnings of 7 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for MiMedx
Group Inc
is $12.00, above its last closing price of $8.26.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.04 0.05 0.06 Beat 33.3
Jun. 30 2023 -0.02 -0.02 0.00 Beat 100
Mar. 31 2023 -0.08 -0.09 -0.06 Beat 30.8
Dec. 31 2022 -0.04 -0.04 -0.02 Beat 45.5
Sep. -0.07 -0.08 -0.09 Missed -16.1
30 2022
Jun. 30 2022 -0.05 -0.06 -0.11 Missed -94.1
Mar. 31 2022 -0.10 -0.10 -0.11 Missed -10
Dec. 31 2021 -0.02 -0.03 0.01 Beat 130
This summary was machine generated February 26 at 23:04 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)